What is the recommended dose of Nordaline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Nortriptyline

The recommended initial dosage of nortriptyline (Nordaline) is 10-25 mg once daily, typically administered at bedtime, with gradual titration up to a maximum of 150 mg per day based on clinical response and tolerability. 1

Dosing Guidelines

Initial Dosing

  • Start with 10-25 mg once daily, preferably at bedtime, for most adult patients 1
  • For elderly patients or those with increased sensitivity to anticholinergic effects, begin with 10 mg daily to minimize adverse effects 1

Dose Titration

  • Increase dose gradually using increments of initial dose every 5-7 days until therapeutic benefits or significant side effects become apparent 1
  • After 9 months of treatment, consider dosage reduction to reassess the need for continued medication 1

Maximum Dosage

  • Maximum recommended dose is 150 mg per day for adults 1
  • For elderly patients, the daily dosage should not exceed 100 mg due to increased risk of adverse effects 1, 2

Special Populations

Elderly Patients

  • Lower starting dose of 10 mg daily is recommended 1
  • Maximum dose should be limited to 100 mg daily due to increased sensitivity to anticholinergic effects 1

Patients with Renal Impairment

  • No significant alteration in nortriptyline metabolism has been observed in patients with chronic renal failure 3
  • However, use with caution and monitor closely due to marked inter-individual differences in drug clearance 3

Therapeutic Monitoring

  • Therapeutic blood level "window" of 50-150 ng/mL (190-570 nmol/L) is recommended for optimal efficacy 1
  • Consider obtaining plasma levels if response is inadequate or toxicity is suspected 4
  • A single 24-hour blood sample can help determine individual patient dosage requirements 4

Clinical Considerations

Efficacy Profile

  • Nortriptyline tends to be activating (reduces apathy) compared to other tricyclic antidepressants 1
  • May be particularly useful in patients with depression accompanied by fatigue or psychomotor retardation 1, 2

Side Effect Profile

  • Lower risk for cardiotoxic, hypotensive, and anticholinergic effects compared to other tricyclic antidepressants 1
  • May cause tachycardia, orthostatic hypotension, sedation, dry mouth, constipation, and urinary retention 1, 2

Common Pitfalls and Precautions

  • Avoid abrupt discontinuation; taper gradually over 10-14 days to limit withdrawal symptoms 1
  • Monitor for orthostatic hypotension, especially with higher initial doses 2
  • Use with caution in patients with cardiovascular disease, as data from a large retrospective study showed increased risk of sudden cardiac death with TCA doses >100 mg/day 1
  • Consider obtaining an electrocardiogram before initiating therapy in patients with cardiovascular risk factors 1

Alternative Medications

  • If nortriptyline is not tolerated, consider alternative antidepressants such as SSRIs (fluoxetine, paroxetine, sertraline) which have different side effect profiles 1, 5
  • For patients requiring both antidepressant and analgesic effects, duloxetine (60-120 mg/day) may be an alternative option 1, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

High initial nortriptyline doses in the treatment of depression.

The Journal of clinical psychiatry, 1993

Research

The pharmacokinetics of nortriptyline in patients with chronic renal failure.

British journal of clinical pharmacology, 1981

Research

Prediction of individual dosage of nortriptyline.

The American journal of psychiatry, 1978

Research

Serotonin and Norepinephrine Reuptake Inhibitors.

Handbook of experimental pharmacology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.